RTN4R and neoplasm: Several biomarkers of tumour-associated angiogenesis are known from the literature, which can be targeted by different peptides (for example: vascular endothelial growth factor (VEGF) derivatives for vascular endothelial growth factor receptor (VEGFR), RGD for integrins and NGR for APN/CD13).